Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
复制标题
胚胎干细胞来源的细胞外囊泡增强间充质干细胞的治疗效果
DOI:
10.7150/thno.35305
复制
发表时间:
2019
期刊:
影响因子:
12.4
通讯作者:
Cui kaige
中科院分区:
文献类型:
--
作者:
Zhang Yan;Xu Jia;Liu Siying;Lim Meikuang;Zhao Shuang;Zhang Kaiyue;Wang Lingling;Ji Qian;Han Zhongchao;Kong Deling;Li Zongjin;Liu Na;Cui kaige
Background: Embryonic stem cells (ES) have a great potential for cell-based therapies in a regenerative medicine. However, the ethical and safety issues limit its clinical application. ES-derived extracellular vesicles (ES-EVs) have been reported suppress cellular senescence. Mesenchymal stem cells (MSCs) are widely used for clinical cell therapy. In this study, we investigated the beneficial effects of ES-EVs on aging MSCs to further enhancing their therapeutic effects. Methods: In vitro, we explored the rejuvenating effects of ES-EVs on senescent MSCs by senescence-associated β-gal (SA-β-gal) staining, immunostaining, and DNA damage foci analysis. The therapeutic effect of senescent MSC pre-treated with ES-EVs was also evaluated by using mouse cutaneous wound model. Results: We found that ES-EVs significantly rejuvenated the senescent MSCs in vitro and improve the therapeutic effects of MSCs in a mouse cutaneous wound model. In addition, we also identified that the IGF1/PI3K/AKT pathway mediated the antisenescence effects of ES-EVs on MSCs. Conclusions: Our results suggested that ES cells derived-extracellular vesicles possess the antisenescence properties, which significantly rejuvenate the senescent MSCs and enhance the therapeutic effects of MSCs. This strategy might emerge as a novel therapeutic strategy for MSCs clinical application.